CRSP Reports $43M Q1 Rev, $1.20 EPS, +120% YoY, Launches Pediatric CASGEVY Submission, Advances In Vivo LNP Pipeline
CRISPR Therapeutics AG · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $54.19
-2.2% in 1d after detection
Post-detection moves
1h
—
1d
-2.2%
3d
-2.2%
7d
-1.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS